Leveraging Human Derived Placental Matrix As a Media Additive to Enhance Expansion of Human Cord Blood CD34+ Cells

Key Points

• Cell expansion improved significantly with the use of placental matrix as a media additive.
• Enhancement was notable with cord blood-derived CD34+ cells, leading to higher yields during culturing.
• Assessment involved comparing growth rates of CD34+ cells with and without the placental matrix.
• This finding suggests potential enhancements for cell therapy applications using placental-derived products.